If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Res Regulatory News (PANR)

Share Price Information for Pantheon Res (PANR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.60
Ask: 30.90
Change: -0.80 (-2.52%)
Spread: 0.30 (0.98%)
Open: 31.35
High: 31.35
Low: 30.50
Prev. Close: 31.80
PANR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Non-Executive Director

9 Mar 2023 12:17

RNS Number : 4741S
Pantheon Resources PLC
09 March 2023
 

9th March, 2023

Pantheon Resources plc

Appointment of Independent Non-Executive Director

 

Pantheon Resources plc ("Pantheon" or "the Company"), the AIM-quoted oil and gas company with a 100% working interest in all of its oil projects spanning c. 153,000 acres adjacent and near to transportation and pipeline infrastructure on the Alaska North Slope ("ANS"), is pleased to announce the appointment of David Hobbs as an Independent Non-Executive Director, effective 21 March 2023. 

 

David graduated as a Petroleum Engineer from Imperial College in 1984, initially working at British Gas as a drilling engineer before moving into commercial and business development roles at Monument Oil & Gas and Hardy Oil and Gas, two UK listed international independent E&P companies. He joined Cambridge Energy Research Associates (CERA), now part of S&P Global, ending up as Chief Energy Strategist, advising Government officials, senior executives and Boards of Directors across the energy sector. He also spent six years as part of the leadership team establishing the King Abdullah Petroleum Studies and Research Center (KAPSARC) in Riyadh, Saudi Arabia. David is an adjunct professor at the University of Calgary.

 

Phillip Gobe, Chairman, of Pantheon Resources, said: "We are delighted to welcome David to the Board as an Independent Non-Executive Director. David has a long-established career in energy strategy, with a demonstrable record of driving success in multiple jurisdictions. He brings a wealth of experience to the team, and I look forward to having him work alongside us as we continue working towards demonstrating the commerciality of our portfolio of an estimated 17.8 billion barrels of oil in place, as recently modelled by SLB Limited (formally known as Schlumberger)."

Commenting on his appointment, David Hobbs said: "Having followed the Pantheon story for a number of years, I am excited to support the Company in refining its strategy to extract the maximum value from its established resource base for shareholders' benefit."

 

Further information in relation to the Director appointment

 

David Alan Hobbs (aged 59) has confirmed that, other than the information disclosed below, there are no matters to be disclosed under Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules.

 

As at the date of appointment, David Hobbs has a total beneficial interest in 1,576,002 ordinary shares of Pantheon, equating to approximately 0.2% of the issued share capital.

 

Previous Directorships

 

SV-Pleione Limited

Polar Energy LLC

 

-ENDS-

 

 

Further information, please contact:

 

Pantheon Resources plc

+44 20 7484 5361

Jay Cheatham, CEO

Justin Hondris, Director, Finance and Corporate Development

 

 

Canaccord Genuity plc (Nominated Adviser and broker)

Henry Fitzgerald-O'Connor, James Asensio, Gordon Hamilton

 

+44 20 7523 8000

 

BlytheRay 

Tim Blythe, Megan Ray, Matthew Bowld

+44 20 7138 3204

 

 

Notes to Editors

Pantheon Resources plc is an AIM listed Oil & Gas company focused on several large projects located on the North Slope of Alaska ("ANS"), onshore USA where it has a 100% working interest in 153,000 highly prospective acres with potential for multi billion barrels of oil recoverable. A major differentiator to other ANS projects is its close proximity to transport and pipeline infrastructure which offers a significant competitive advantage to Pantheon, allowing for materially lower capital costs and much quicker development times. The Group's stated objective is to create material value for its stakeholders through oil exploration, appraisal and development activities in high impact, highly prospective conventional assets, in the USA; a highly established region for energy production with infrastructure, skilled personnel and low sovereign risk. All operations are onshore USA, with drilling costs materially below that of offshore wells.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUQGWUPWGPB
Date   Source Headline
7th Feb 20227:00 amRNSTalitha #A Testing Update
24th Jan 20224:53 pmRNSWebinar
24th Jan 202212:17 pmRNSResult of AGM
24th Jan 20227:00 amRNSSpudding of Theta West #1 Well & Operations Update
20th Jan 20227:00 amRNSExercise of Warrants
19th Jan 20227:02 amRNSAnnual Grant of Share Options to Directors & Staff
19th Jan 20227:00 amRNSDirector/PDMR Notification
13th Jan 20227:00 amRNSIssue of Equity & Exercise of Share Options
12th Jan 20229:10 amRNSTheta West Drilling Permit Approval & AGM Webinar
7th Jan 202212:05 pmRNSAnnual General Meeting & Covid Precautions
6th Jan 20227:00 amRNSOperations Update
4th Jan 20227:00 amRNSTR-1: Notification of major holdings
17th Dec 20219:23 amRNSTR-1: Notification of major holdings
17th Dec 20217:00 amRNSOperations Update
16th Dec 20217:00 amRNSTR-1: Notification of major holdings
8th Dec 20217:00 amRNSResult of Capital Raise
7th Dec 20214:58 pmRNSRetail Offer via PrimaryBid
7th Dec 20214:51 pmRNSProposed Placing and Subscription
7th Dec 20214:42 pmRNSFinal Results for the Year Ended 30 June 2021
2nd Dec 20217:00 amRNSTR-1: Notification of major holdings
25th Nov 20215:30 pmRNSSilence Therapeutics
17th Nov 20217:00 amRNSShort term draw down facility to secure equipment
12th Nov 20215:16 pmRNSNotification of Major Holdings
22nd Oct 20216:13 pmRNSStandard form for notification of major holdings
15th Oct 20217:00 amRNSIssue of Equity
28th Sep 20215:23 pmRNSTR-1: Notification of major holdings
17th Sep 20215:13 pmRNSNotification of Major Holdings
7th Sep 20215:23 pmRNSTR-1: Notification of major holdings
2nd Sep 20211:35 pmRNSIssue of Equity
2nd Sep 202111:31 amRNSTR-1: Notification of major holdings
26th Aug 20217:00 amRNSWebinar & Corporate Update
25th Aug 202112:00 pmRNSRescheduling of Webinar to Thursday 26 August 2021
19th Aug 20217:00 amRNSUpdate on Forthcoming Webinar
11th Aug 20217:00 amRNSWebinar & Corporate Update
6th Aug 20217:00 amRNSTR-1: Notification of major holdings
5th Aug 20217:21 amRNSTR-1: Notification of major holdings
29th Jul 20217:00 amRNSConversion of Shares
16th Jul 20217:00 amRNSManagement Resource Upgrade & Investor Webinar
25th Jun 20217:00 amRNSTR-1: Notification of major holdings
4th Jun 20215:30 pmRNSTR-1: Notification of major holdings
26th May 20215:26 pmRNSTR-1: Notification of major holdings
20th May 20215:13 pmRNSTR-1: Notification of major holdings
17th May 20217:00 amRNSResource Upgrade – Basin Floor Fan
13th May 202110:42 amRNSCorrection - Conversion of Shares
13th May 20217:00 amRNSConversion of Shares
6th May 202112:43 pmRNSTR-1: Notification of major holdings
23rd Apr 20212:11 pmRNSDirector/PDMR Notification
20th Apr 20212:41 pmRNSTalitha #A, Baker Hughes AHS VAS Report
19th Apr 20217:00 amRNSOperational update, Talitha #A well
16th Apr 20211:12 pmRNSAIM Rule 17 and Schedule 2(g) Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.